Infectious Disease Doctors in Spokane, WA Accepting Medicare

6 Infectious Disease doctors found. Showing 1 - 6

Dr. Maria Christine Yurasek, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 4815 N Assembly St, Spokane, WA 99205 Phone: 509-434-7000

Timothy D Maughan, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 624 E Front Ave, Spokane, WA 99202 Phone: 509-626-9904

Dr. Patrick O'malley Tennican, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 665 N. Riverpoint Blvd., Suite 410, Spokane, WA 99202 Phone: 509-994-4423    Fax: 509-443-7036

Michael D Gillum, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 624 E Front Ave, Spokane, WA 99202 Phone: 509-626-9904

Henry L Arguinchona, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 624 E Front Ave, Spokane, WA 99202 Phone: 509-626-9900

Hui Quan Katie Zhang, Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 624 E Front Ave, Spokane, WA 99202 Phone: 509-626-9900

News Archive

Study examines young adults' perceptions of complete and fragmentary blackouts

Blackouts refer to partial or complete memory loss of events that occur while individuals are drinking. These individuals maintain consciousness during the event and may even be able to engage in complex behaviors such as conversing or driving.

Researchers find concussion as leading cause of injury for children in recreational sports

Elementary school-aged children who participate in recreational sports are at greater risk of concussion than most other sports-related injuries. A new study published in PLOS ONE focused on children 5-11 years old who play recreational football, soccer and baseball/softball.

L2FU reports 100% recovery of recent study's lost clinical trial patients

Recovering unnecessarily lost patient information is now a viable reality. Lost to follow up rates in clinical research trials can range from 20- 60%. As a result, patients who drop from a clinical trial and 'go missing' can impart a major set-back in pharmaceutical research. Failure to contact patients and obtain final closure data, or bring them back into the clinical trial (if the protocol allows) results in study delays, increased patient recruitment costs, compromised study data, and in some cases an insufficient amount of information to prove the safety and efficacy of a drug.

How the health law is playing in the states

The Washington Post offers a table documenting how the overhaul is doing while USA Today chronicles successes and failures in three specific states.

New breast cancer drug combo could save thousands of lives

New hope has been given to thousands of women living in dread of the return of an aggressive form of breast cancer.

Read more Medical News

› Verified 6 days ago